Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2010Journal of Clinical and Experimental DentistryOpen Access

Dabigatran and rivaroxaban, new oral anticoagulants. New approaches in Dentistry

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Do dabigatran and rivaroxaban facilitate dental management compared to traditional vitamin K antagonists in patients with atrial fibrillation or venous thromboembolism?

Population

Patients with atrial fibrillation or venous thromboembolism requiring dental management

Comparison

Dabigatran and rivaroxaban vs Vitamin K antagonists (traditional anticoagulants)

Design

Review

Authors

GMGerardo Gómez MorenoAAAntonio Aguilar‐SalvatierraMMMiguel Ángel Martín‐Piedra

Discussion

Loading...

Member takes

Overview

May facilitate dental procedures without monitoring; leaves open prospective comparisons with vitamin K antagonists.

Structured PICO

Do dabigatran and rivaroxaban facilitate dental management compared to traditional vitamin K antagonists in patients with atrial fibrillation or venous thromboembolism?

P
Population
Patients with atrial fibrillation or venous thromboembolism requiring dental management
I
Intervention
Dabigatran and rivaroxaban
C
Comparator
Vitamin K antagonists (traditional anticoagulants)
O
Outcome
Facilitation of dental management

Dabigatran and rivaroxaban simplify dental management for anticoagulated patients by eliminating the need for routine laboratory monitoring and offering favorable drug interaction profiles.

Cite This Study

Moreno et al. (2010) studied this question.

synapsesocial.com/papers/6a758252ef3d015f2ddd75cehttps://doi.org/10.4317/jced.2.e1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The novel anticoagulants: entering a new era2009 · 66 citations
  2. 2New oral anticoagulants in atrial fibrillation2007 · 181 citations
  3. 3Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty2008 · 1,302 citations
  4. 4Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty2008 · 1,439 citations
  5. 5Dabigatran versus Warfarin in Patients with Atrial Fibrillation2009 · 11,272 citations